Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Express Scripts
Harvard Business School
Johnson and Johnson
Colorcon

Last Updated: December 6, 2022

CLINICAL TRIALS PROFILE FOR LORCASERIN HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Lorcaserin Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00395135 ↗ BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management Completed Arena Pharmaceuticals Phase 3 2006-11-01 The purpose of this study is to assess the weight loss effect of lorcaserin at the end of the first year of treatment (Week 52) and to assess the ability of lorcaserin to maintain weight loss at the end of the second year of treatment (Week 104)
NCT00395135 ↗ BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management Completed Eisai Inc. Phase 3 2006-11-01 The purpose of this study is to assess the weight loss effect of lorcaserin at the end of the first year of treatment (Week 52) and to assess the ability of lorcaserin to maintain weight loss at the end of the second year of treatment (Week 104)
NCT00603291 ↗ BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus Completed Arena Pharmaceuticals Phase 3 2007-12-01 The purpose of this study is to assess the weight loss effect of lorcaserin during and at the end of 1 year of treatment in overweight and obese patients with Type II diabetes mellitus treated with metformin, sulfonylurea (SFU), or either agent in combination with other oral hypoglycemic agents.
NCT00603291 ↗ BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus Completed Eisai Inc. Phase 3 2007-12-01 The purpose of this study is to assess the weight loss effect of lorcaserin during and at the end of 1 year of treatment in overweight and obese patients with Type II diabetes mellitus treated with metformin, sulfonylurea (SFU), or either agent in combination with other oral hypoglycemic agents.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lorcaserin Hydrochloride

Condition Name

Condition Name for Lorcaserin Hydrochloride
Intervention Trials
Obesity 13
Overweight 3
Smoking Cessation 3
Weight Gain 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Lorcaserin Hydrochloride
Intervention Trials
Overweight 11
Obesity 8
Disease 8
Weight Loss 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lorcaserin Hydrochloride

Trials by Country

Trials by Country for Lorcaserin Hydrochloride
Location Trials
United States 132
Canada 9
China 8
New Zealand 6
Australia 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Lorcaserin Hydrochloride
Location Trials
California 11
New York 10
Florida 7
Ohio 7
North Carolina 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lorcaserin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Lorcaserin Hydrochloride
Clinical Trial Phase Trials
Phase 4 6
Phase 3 6
Phase 2/Phase 3 2
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Lorcaserin Hydrochloride
Clinical Trial Phase Trials
Completed 26
Terminated 10
Active, not recruiting 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lorcaserin Hydrochloride

Sponsor Name

Sponsor Name for Lorcaserin Hydrochloride
Sponsor Trials
Eisai Inc. 16
Arena Pharmaceuticals 11
National Institute on Drug Abuse (NIDA) 10
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Lorcaserin Hydrochloride
Sponsor Trials
Other 33
Industry 30
NIH 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Dow
Express Scripts
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.